INSIGHT REPORT CALENDAR

NEWSLETTER

Like this article?

Sign up to our free newsletter

Blue Heron Capital to invest in TRICAST

Blue Heron Capital has a closed an investment in TRICAST, a healthcare IT company focused on pharmacy benefit data monitoring and analytics. Brook Venture Partners of Wakefield, MA participated in the investment.

“This is an exciting next step in the evolution of TRICAST,” says CEO Greg Rucinski. “The support of our investors will enable us to increase our pace of growth, accelerate our Reveal development efforts and devote more resources to providing an outstanding customer experience.”
 
TRICAST is the developer of the first real-time pharmacy benefit data monitoring and analytics solution targeting compliance with CMS regulations and a reduction of fraud, waste and abuse, a more than USD250 billion annual cost in the US healthcare system. This investment provides the necessary capital for TRICAST CEO, Greg Rucinski (pictured), to develop new modules for their SaaS software platform and expand the sales and onboarding team to drive additional growth.
 
Andrew Tichenor, Partner at Blue Heron Capital, says: “We are seeing a historic change in healthcare and believe costs must be contained. Through our operational expertise, Blue Heron Capital looks forward to helping TRICAST identify and remedy the significant fraud and waste that occurs in the pharmacy benefit space.”

Like this article? Sign up to our free newsletter

FEATURED

Tech Stocks

MOST RECENT

FURTHER READING